Becton Dickinson & Co. Hits New 52-Week High at $105.02 (BDX)
Shares of Becton Dickinson & Co. (NYSE:BDX) hit a new 52-week high on Friday, Stock Ratings News reports. The company traded as high as $105.02 and last traded at $104.91, with a volume of 468,330 shares trading hands. The stock had previously closed at $104.09.
A number of analysts have recently weighed in on BDX shares. Analysts at SunTrust initiated coverage on shares of Becton Dickinson & Co. in a research note to investors on Friday, October 11th. They set a “buy” rating on the stock. Separately, analysts at Zacks reiterated a “neutral” rating on shares of Becton Dickinson & Co. in a research note to investors on Wednesday, September 25th. They now have a $106.00 price target on the stock. Finally, analysts at Piper Jaffray Cos. upgraded shares of Becton Dickinson & Co. from a “neutral” rating to an “overweight” rating in a research note to investors on Wednesday, September 18th. They now have a $117.00 price target on the stock, up previously from $91.00. Two investment analysts have rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Hold” and an average price target of $103.04.
Becton Dickinson & Co. has a 52 week low of $74.18 and a 52 week high of $105.02. The stock’s 50-day moving average is $100.6 and its 200-day moving average is $99.28. The company has a market cap of $20.355 billion and a price-to-earnings ratio of 13.96.
Becton Dickinson & Co. (NYSE:BDX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.58 earnings per share for the quarter, beating the analysts’ consensus estimate of $1.48 by $0.10. The company had revenue of $2.05 billion for the quarter, compared to the consensus estimate of $2.05 million. During the same quarter last year, the company posted $1.52 earnings per share. Becton Dickinson & Co.’s revenue was up 3.6% compared to the same quarter last year. On average, analysts predict that Becton Dickinson & Co. will post $5.75 earnings per share for the current fiscal year.
Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.